CBG #18

CBG #18 is a specialized cannabis strain bred specifically for high cannabigerol (CBG) content, representing a distinct category of cannabis cultivars focused on non-intoxicating cannabinoids. Unlike traditional strains selected primarily for THC or CBD content, CBG #18 was developed through selective breeding to maximize CBG production while minimizing THC levels. The strain emerged in the 2010s as research into minor cannabinoids gained momentum, with breeders recognizing CBG's potential therapeutic applications. Its development reflects the growing diversification of cannabis genetics beyond psychoactive properties.

Visually, CBG #18 typically exhibits characteristics common to industrial hemp varieties, with tall, lanky growth patterns and relatively sparse branching. The buds are often smaller and less dense than those of high-THC strains, with light green coloration and minimal trichome coverage compared to resin-rich psychoactive varieties. The plant's appearance prioritizes cannabinoid production over aesthetic qualities, with breeders focusing on maximizing CBG yield per plant. The strain's flowering structure is optimized for efficient extraction rather than traditional consumption methods.

Notably, CBG #18 represents a significant departure from conventional cannabis breeding objectives. While most cannabis history has centered on maximizing psychoactive effects, this strain exemplifies the industry's shift toward therapeutic applications without intoxication. The development of high-CBG strains like CBG #18 has been instrumental in creating standardized sources of this minor cannabinoid for research and product development. As a relatively new addition to the cannabis genetic landscape, CBG #18 continues to evolve through further breeding refinement.